Cartesian Therapeutics (RNAC) Revenue (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Revenue of $78000.0 for Q1 2026, down 92.91% year-over-year from $1.1 million in Q1 2025, and up 105.38% quarter-over-quarter from -$1.4 million in Q4 2025.
Cartesian Therapeutics (RNAC) Revenue (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Revenue data on file, last reported at $78000.0 in Q1 2026.
- Revenue for Q1 2026 came in at $78000.0, down 92.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$920000.0 (down 102.76% YoY), and the FY2025 annual result was $400000.0, down 98.95% from the prior year.
- Revenue rose to $78000.0 in Q1 2026 per RNAC's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Revenue peaked at $39.3 million in Q2 2022 and troughed at -$1.4 million in Q4 2025.
- A 5-year average of $10.9 million and a median of $5.9 million in 2023 frame the typical range for Revenue.
- On a YoY basis, Revenue climbed as much as 533.85% in 2024 and fell as far as 116.9% in 2024.
- A 5-year view of Revenue shows it stood at $16.8 million in 2022, then tumbled by 50.78% to $8.3 million in 2023, then tumbled by 116.9% to -$1.4 million in 2024, then decreased by 3.79% to -$1.4 million in 2025, then surged by 105.38% to $78000.0 in 2026.
- Business Quant data shows RNAC's Revenue at $78000.0 in Q1 2026, -$1.4 million in Q4 2025, and $452000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | 452,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 33.27 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 20.71 Mn |
| Jun 30, 2022 | 39.27 Mn |
| Mar 31, 2022 | 34.00 Mn |
| Dec 31, 2021 | 29.94 Mn |
| Sep 30, 2021 | 24.43 Mn |
| Jun 30, 2021 | 19.66 Mn |
| Mar 31, 2021 | 11.05 Mn |